Transcription of JPMA Code of Practice
{{id}} {{{paragraph}}}
1 JPMA code of Practice (Established on January 16, 2013) (Enforced on April 1, 2013) (Revised on May 25, 2017) (Enforced on October 1, 2017) Japan pharmaceutical Manufacturers Association (JPMA) [Preamble] Japan pharmaceutical Manufacturers Association (JPMA) was established in 1968 as an organization of R&D-based pharmaceutical companies. The member companies of JPMA consider it their mission to contribute to improvements in the health and welfare of people in Japan and throughout the world through the development of safer, innovative, and highly useful pharmaceuticals. To support optimal medical care that is ethical and patient-oriented, JPMA calls upon member companies to build mutual relationships of trust with researchers, healthcare professionals, and patient organizations through appropriate industry-academia collaborations.
1 JPMA Code of Practice (Established on January 16, 2013) (Enforced on April 1, 2013) (Revised on May 25, 2017) (Enforced on October 1, 2017) Japan Pharmaceutical Manufacturers Association (JPMA)
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}